Showing results (151-160 of 776) with videos related to
Sort By:
Pageof 78
Thrombosis and Haemostasis|June 30, 1981
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitroO Matsuo, D C Rijken, D CollenThrombosis and Haemostasis|October 1, 1981
Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in cultureK Bykowska, D C Rijken, D CollenCurrent Gene Therapy|July 12, 2002
Viral vector-mediated gene therapy for hemophiliaT VandenDriessche, D Collen, M K ChuahThrombosis and Haemostasis|December 27, 1982
Partial primary structure of human alpha 2-antiplasmin-homology with other plasma protease inhibitorsH R Lijnen, B Wiman, D CollenBiochimica Et Biophysica Acta|July 25, 1979
On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogenB Wiman, H R Lijnen, D CollenStroke|September 26, 1997
Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke modelS Vanderschueren, I Van Vlaenderen, D CollenBlood|January 1, 1988
Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbitsD Collen, J M Stassen, G LarsenEuropean Journal of Biochemistry|November 1, 1991
Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cellsE A Thompson, L Nelles, D CollenThe Journal of Biological Chemistry|September 25, 1986
Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasmaD C Stump, M Thienpont, D CollenEuropean Journal of Biochemistry|July 1, 1986
Characterization of functional domains in human tissue-type plasminogen activator with the use of monoclonal antibodiesP Holvoet, H R Lijnen, D CollenPageof 78